NasdaqGS - Nasdaq Real Time Price • USD
Stoke Therapeutics, Inc. (STOK)
As of 3:37 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 169,960 | 9 |
| Sales | 3,731,728 | 12 |
| Net Shares Purchased (Sold) | -3,561,768 | 21 |
| Total Insider Shares Held | 2.12M | -- |
| % Net Shares Purchased (Sold) | -62.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SKORPIOS TRUST Trustee | Sale at price 11.60 per share. | Indirect | 41,760,000 | Apr 17, 2024 |
| NASH HUW M. Chief Operating Officer | Sale at price 13.22 - 13.61 per share. | Direct | 811,212 | Apr 1, 2024 |
| NASH HUW M. Chief Operating Officer | Conversion of Exercise of derivative security at price 0.40 per share. | Direct | 20,000 | Apr 1, 2024 |
| TICHO BARUCH S Officer | Sale at price 13.23 per share. | Direct | 124,684 | Apr 1, 2024 |
| TICHO BARUCH S Officer | Conversion of Exercise of derivative security at price 0.60 per share. | Direct | 265 | Apr 1, 2024 |
| ALLAN JONATHAN General Counsel | Sale at price 13.19 - 13.81 per share. | Direct | 67,668 | Mar 28, 2024 |
| TULIPANO STEPHEN J Chief Financial Officer | Sale at price 6.10 per share. | Direct | 25,102 | Mar 19, 2024 |
| KAYE EDWARD M Chief Executive Officer | Sale at price 6.10 per share. | Direct | 67,999 | Mar 19, 2024 |
| NASH HUW M. Chief Operating Officer | Sale at price 6.10 per share. | Direct | 25,102 | Mar 19, 2024 |
| TICHO BARUCH S Officer | Sale at price 6.10 per share. | Direct | 25,102 | Mar 19, 2024 |
| ALLAN JONATHAN General Counsel | Sale at price 6.10 per share. | Direct | 14,326 | Mar 19, 2024 |
| TULIPANO STEPHEN J Chief Financial Officer | -- | Direct | -- | Mar 15, 2024 |
| KAYE EDWARD M Chief Executive Officer | -- | Direct | -- | Mar 15, 2024 |
| NASH HUW M. Chief Operating Officer | -- | Direct | -- | Mar 15, 2024 |
| TICHO BARUCH S Officer | -- | Direct | -- | Mar 15, 2024 |
| ALLAN JONATHAN General Counsel | -- | Direct | -- | Mar 15, 2024 |
| TICHO BARUCH S Officer | Sale at price 7.75 per share. | Direct | 77,469 | Mar 1, 2024 |
| TICHO BARUCH S Officer | Conversion of Exercise of derivative security at price 0.60 per share. | Direct | 3,302 | Mar 1, 2024 |
| TZIANABOS ARTHUR Director | Conversion of Exercise of derivative security at price 2.19 per share. | Direct | 69,508 | Feb 13, 2024 |
| TICHO BARUCH S Officer | Sale at price 4.80 per share. | Direct | 47,991 | Feb 1, 2024 |
| TICHO BARUCH S Officer | Sale at price 5.74 per share. | Direct | 57,352 | Jan 2, 2024 |
| TICHO BARUCH S Officer | Sale at price 10.60 per share. | Direct | 158,973 | Jul 3, 2023 |
| ALLAN JONATHAN General Counsel | Sale at price 13.48 per share. | Direct | 26,252 | Jun 21, 2023 |
| TICHO BARUCH S Officer | Sale at price 11.13 per share. | Direct | 166,964 | Jun 1, 2023 |
| TICHO BARUCH S Officer | Sale at price 10.00 per share. | Direct | 6,530 | May 4, 2023 |
| TICHO BARUCH S Officer | Sale at price 10.00 - 10.14 per share. | Direct | 555,267 | May 3, 2023 |
| KAYE EDWARD M Chief Executive Officer | Conversion of Exercise of derivative security at price 0.60 per share. | Direct | 12,000 | Mar 27, 2023 |
| TICHO BARUCH S Officer | Sale at price 10.02 - 10.03 per share. | Direct | 130,236 | Feb 6, 2023 |
| TICHO BARUCH S Officer | Sale at price 10.00 - 10.02 per share. | Direct | 61,810 | Feb 2, 2023 |
| TULIPANO STEPHEN J Chief Financial Officer | Conversion of Exercise of derivative security at price 4.48 per share. | Direct | 49,997 | Jun 2, 2022 |
| KAYE EDWARD M Chief Executive Officer | Conversion of Exercise of derivative security at price 0.60 per share. | Direct | 9,000 | May 25, 2022 |
| NASH HUW M. Chief Operating Officer | Sale at price 22.47 - 24.07 per share. | Direct | 87,666 | Jan 3, 2022 |
| NASH HUW M. Chief Operating Officer | Conversion of Exercise of derivative security at price 2.19 per share. | Direct | 8,322 | Jan 3, 2022 |
| NASH HUW M. Chief Operating Officer | Sale at price 23.96 - 25.06 per share. | Direct | 139,330 | Dec 1, 2021 |
| NASH HUW M. Chief Operating Officer | Conversion of Exercise of derivative security at price 2.19 per share. | Direct | 12,483 | Dec 1, 2021 |
| NASH HUW M. Chief Operating Officer | Sale at price 23.41 - 25.00 per share. | Direct | 136,956 | Nov 3, 2021 |
| NASH HUW M. Chief Operating Officer | Conversion of Exercise of derivative security at price 2.19 per share. | Direct | 12,483 | Nov 3, 2021 |
| NASH HUW M. Chief Operating Officer | Sale at price 24.83 per share. | Direct | 141,506 | Oct 1, 2021 |
| NASH HUW M. Chief Operating Officer | Conversion of Exercise of derivative security at price 2.19 per share. | Direct | 12,483 | Oct 1, 2021 |
| NASH HUW M. Chief Operating Officer | Sale at price 26.00 per share. | Direct | 148,223 | Sep 1, 2021 |
| NASH HUW M. Chief Operating Officer | Conversion of Exercise of derivative security at price 2.19 per share. | Direct | 12,483 | Sep 1, 2021 |
| NASH HUW M. Chief Operating Officer | Sale at price 28.87 per share. | Direct | 164,554 | Aug 2, 2021 |
| NASH HUW M. Chief Operating Officer | Conversion of Exercise of derivative security at price 2.19 per share. | Direct | 12,483 | Aug 2, 2021 |
| TICHO BARUCH S Officer | Sale at price 32.68 - 33.55 per share. | Direct | 1,413,654 | Jul 13, 2021 |
| NASH HUW M. Chief Operating Officer | Sale at price 33.33 per share. | Direct | 189,987 | Jul 1, 2021 |
| NASH HUW M. Chief Operating Officer | Conversion of Exercise of derivative security at price 2.19 per share. | Direct | 12,483 | Jul 1, 2021 |
| NASH HUW M. Chief Operating Officer | Sale at price 39.43 per share. | Direct | 22,669 | Jun 1, 2021 |
| NASH HUW M. Chief Operating Officer | Conversion of Exercise of derivative security at price 2.19 per share. | Direct | 1,259 | Jun 1, 2021 |
| LIAU GENE Officer | Sale at price 58.73 - 63.52 per share. | Direct | 336,297 | Mar 2, 2021 |
| LIAU GENE Officer | Conversion of Exercise of derivative security at price 0.60 per share. | Direct | 7,917 | Mar 2, 2021 |
Related Tickers
AKRO Akero Therapeutics, Inc.
19.57
+3.38%
ACRV Acrivon Therapeutics, Inc.
8.48
+0.12%
STRO Sutro Biopharma, Inc.
3.4800
+1.75%
BDTX Black Diamond Therapeutics, Inc.
5.83
+14.09%
CGEM Cullinan Therapeutics, Inc.
25.18
+30.81%
IGMS IGM Biosciences, Inc.
9.15
+19.58%
SANA Sana Biotechnology, Inc.
8.72
+2.56%
YMAB Y-mAbs Therapeutics, Inc.
14.60
-1.62%
NKTX Nkarta, Inc.
6.82
0.00%
ALEC Alector, Inc.
5.28
+9.77%